Organization
Vico Therapeutics
1 clinical trial
Clinical trial
A Phase 1/2a, Open-label Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of Intrathecally Administered VO659 in Participants With Spinocerebellar Ataxia Types 1, 3 and Huntington's DiseaseStatus: Recruiting, Estimated PCD: 2025-09-01